4 Questions About GLP-1s for Weight Loss That People Are Secretly Searching Online

If you’re taking or considering starting a glucagon-like peptide-1 (GLP-1) medication to manage obesity, it’s normal to have questions you may hesitate to bring up with your doctor. These can range from concerns about appetite suppression to expectations around weight loss progress or the stigma of turning to medication for help. Time constraints during visits or uncertainty about what’s “appropriate” to ask can make it hard to speak up, but these concerns are incredibly common.
Hearing the kinds of questions others have asked about using GLP-1s for weight management — even the questions people feel embarrassed to say out loud — can help you feel less alone and more inclined to bring them up at your next visit.
1. Am I ‘Cheating’ by Using a GLP-1 for Obesity?
WHAT THE RESEARCH SAYS

WHY TO BRING IT UP WITH YOUR DOCTOR

2. Is It Normal to Have No Appetite or Barely Eat While Taking a GLP-1 Medication?
WHAT THE RESEARCH SAYS

WHY TO BRING IT UP WITH YOUR DOCTOR

There’s a difference between eating less and barely eating at all. If you’re regularly skipping meals, struggling to eat, or feeling weak, dizzy, or overly fatigued, it’s important to discuss it with your doctor.
In some cases, your doctor may need to adjust the dose, especially after you start treatment or move to a higher dose. Your doctor may also recommend working with a registered dietitian to develop an eating plan that ensures you’re meeting your nutritional needs, even when you’re not hungry.
3. Why Am I Not Losing Weight as Fast as Others Who Take GLP-1s?
WHAT THE RESEARCH SAYS

WHY TO BRING IT UP WITH YOUR DOCTOR

It’s completely valid to feel discouraged when your weight loss progress doesn’t match what you see from others, whether online or in real life. But response to GLP-1 medications varies widely.
Your doctor can help set realistic expectations based on your starting weight, health history, and other factors that influence how your body may respond to these medications. They can also tell you whether the results you’re seeing along the way are in normal range. If needed, they may adjust your treatment plan or explore additional strategies to support your progress over time.
4. Do I Have to Stay on GLP-1 Medications Forever, and Will I Regain the Weight if I Stop?
WHAT THE RESEARCH SAYS

This is likely because the underlying biology surrounding obesity persists. Experts now view obesity as a chronic condition, where ongoing GLP-1 treatment can be used for long-term management, similar to conditions such as high blood pressure or type 2 diabetes.
WHY TO BRING IT UP WITH YOUR DOCTOR

It’s very common to wonder whether GLP-1 medications are meant to be temporary or long term, and there’s no single answer that fits everyone’s circumstances. Your doctor can help you understand what long-term treatment might look like, including whether a maintenance dose, gradual taper, or transition off the medication will eventually be appropriate for you. They can also help you plan out other weight management strategies to support your goals in the long run.
- Tomiyama AJ. Behavioral Medicine in the GLP-1 Era. Annals of Behavioral Medicine. January 4, 2025.
- Standen EC et al. An Experimental Investigation of the Stigmatization of Weight Loss and Regain From GLP-1 Receptor Agonist Use and Cessation. International Journal of Obesity. April 3, 2026.
- Lau J. Diet, Exercise Still Important When Taking Weight-Loss Medication. Harvard T.H. Chan School of Public Health. August 28, 2025.
- Naveed M et al. GLP-1 Medication and Weight Loss: Barriers and Motivators Among 1659 Participants Managed in a Virtual Setting. Diabetes, Obesity and Metabolism. July 2025.
- Prescription Medications to Treat Overweight & Obesity. National Institute of Diabetes and Digestive and Kidney Diseases. June 2024.
- Bashir A. Malnutrition With Use of GLP-1 Agonists Is an Underestimated Real World Harm. BMJ. July 25, 2025.
- Su QJ et al. Genetic Predictors of GLP1 Receptor Agonist Weight Loss and Side Effects. Nature. May 21, 2026.
- Steps for Losing Weight. Centers for Disease Control and Prevention. January 17, 2025.
- Kolli RT et al. Rebound or Retention: A Meta-Analysis of Weight Regain After the Discontinuation of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Other Anti-Obesity Drugs. Cureus. October 19, 2025.
- West S et al. Weight Regain After Cessation of Medication for Weight Management: Systematic Review and Meta-Analysis. BMJ. January 7, 2026.

Sean Hashmi, MD
Medical Reviewer
Sean Hashmi, MD, is an experienced nephrologist and obesity medicine specialist based in Southern California. As the regional director for clinical nutrition and weight management ...
